You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 紅日藥業連續第二日一字板 血必淨獲批用於重型危重型新冠肺炎
格隆匯 04-16 14:37
格隆匯4月16日丨紅日藥業(300026.SZ)連續第二日一字板,報6.53元,總市值196億元。紅日藥業本週二收盤後公告,公司近日收到國家藥品監督管理局下發的關於公司產品血必淨注射液新增適應症的《藥品補充申請批件》,批准血必淨注射液説明書“功能主治”項增加“可用於新型冠狀病毒肺炎重型、危重型的全身炎症反應綜合徵或/和多臟器功能衰竭。”,“用法與用量”項增加“用於新型冠狀病毒肺炎:100ml加0.9%氯化鈉注射液250ml稀釋,一天2次。”公司預計血必淨注射液的適應症增項將對該產品的市場推廣和銷售產生積 極影響,但對公司經營業績的影響暫無法估計。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account